New drug ZE74-0282 tested in healthy volunteers for first time
NCT ID NCT07527221
First seen Apr 19, 2026 · Last updated May 20, 2026 · Updated 9 times
Summary
This is a first-in-human study to check the safety and tolerability of a new drug called ZE74-0282. It involves 40 healthy adults aged 18 to 55 who will receive either the drug or a placebo. The main goal is to monitor side effects and how the drug moves through the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Scientia Clinical Research Ltd.
Randwick, New South Wales, 2031, Australia
Conditions
Explore the condition pages connected to this study.